← back to search

Rochelle Castillo

Boston Children's Hospital · US
Area of research
Rheumatology · Epidemiology
Research interest
Research interests include Inflammatory Myopathies and Dermatomyositis, Systemic Lupus Erythematosus Research, Psoriasis: Treatment and Pathogenesis, and Spondyloarthritis Studies and Treatments.
h-index
14
citations
1,412
works
49
NIH funding
—
primary concept
Medicine
email
rcastillo@uchc.edu

Recent publications

Metabolic coordination between skin epithelium and type 17 immunity sustains chronic skin inflammation
Immunity 2024cited by 76position: middledoi
Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study
Journal of the American Academy of Dermatology 2024cited by 21position: middledoi
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial
BMJ Open 2022cited by 51position: middledoi
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
Annals of the Rheumatic Diseases 2021cited by 266position: middledoi
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
The Lancet Rheumatology 2021cited by 24position: middledoi
Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis
Annals of Translational Medicine 2021cited by 20position: firstdoi
Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
New England Journal of Medicine 2020cited by 420position: middledoi
COVID‐19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease‐Modifying Antirheumatic Drugs on Clinical Outcomes
Arthritis & Rheumatology 2020cited by 112position: middledoi
Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients With Systemic Lupus Erythematosus
Arthritis & Rheumatology 2020cited by 63position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

José U. Scher · NYU Langone Health5 papers (2020–2024)Rebecca H. Haberman · New York University4 papers (2020–2022)Andrea L. Neimann · Brigham and Women's Hospital3 papers (2020–2022)Peter Izmirly · NYU Langone Health3 papers (2020–2020)Di Yan · Beijing University of Agriculture2 papers (2020–2020)Alisa N. Femia · New York University2 papers (2021–2024)Samrachana Adhikari · NYU Langone Health2 papers (2020–2020)Alexis Ogdie · Hospital of the University of Pennsylvania2 papers (2020–2022)Alan Chen · Albany State University2 papers (2020–2020)Niroshana Anandasabapathy · New York Proton Center1 papers (2024–2024)Sydney Catron · New York University1 papers (2022–2022)Joseph F. Merola · Southwestern Medical Center1 papers (2022–2022)Aristotelis Tsirigos · NYU Langone Health1 papers (2024–2024)Kimberly B. Hashemi · Medical University of South Carolina1 papers (2024–2024)Shruti Naik · Icahn School of Medicine at Mount Sinai1 papers (2024–2024)Mala Masson · New York University1 papers (2020–2020)Jiyuan Hu · New York University1 papers (2022–2022)H. Michael Belmont · NYU Langone Health1 papers (2020–2020)Jóhann E. Guðjónsson · Nexus Clinical Research (Canada)1 papers (2024–2024)Ralf Thiele · Hochschule Bonn-Rhein-Sieg1 papers (2022–2022)